Semaglutide vs Tirzepatide vs Retatrutide

Semaglutide

Tirzepatide

Retatrutide

Three lipidated peptide analogs, distinguished by receptor breadth

Comparison table

Characteristic Semaglutide Tirzepatide Retatrutide
Receptor classification GLP-1 mono-agonist GIP and GLP-1 dual agonist GIP, GLP-1, and glucagon tri-agonist
Peptide family Glucagon-superfamily analog Glucagon-superfamily analog Glucagon-superfamily analog
Peptide structure Linear synthetic peptide Linear synthetic peptide Linear synthetic peptide
Reported chain length 31 amino acid residues 39 amino acid residues 39 amino acid residues
Lipidation Present Present Present
General research format Lyophilized peptide powder Lyophilized peptide powder Lyophilized peptide powder
Common identity methods HPLC and mass spectrometry HPLC and mass spectrometry HPLC and mass spectrometry

What is the main difference between the three?

Semaglutide

Tirzepatide

Retatrutide

Receptor classification by compound

Semaglutide: GLP-1 mono-agonist

Tirzepatide: GIP and GLP-1 dual agonist

Retatrutide: GIP, GLP-1, and glucagon tri-agonist

Peptide class and backbone structure

Chain length comparison

Lipidation and conjugate chemistry

Linker architecture may include

Amino acid engineering

Molecular profile comparison

Why lot-specific documentation matters

Physical format and analytical identification

Reversed-phase high-performance liquid chromatography

Mass spectrometry

Additional characterization

Shared features and key differences

Shared structural features

Key structural differences

Frequently asked questions

A synthetic incretin-peptide design continuum